Merit Medical Systems Inc. looks to ingest Pentax Medical’s C2 cryoballoon through a $22 million asset purchase expected to close Nov. 1. The C2 treats Barrett’s esophagus, which can be a precursor to esophageal cancer, as well as gastric antral vascular ectasia syndrome. The deal includes a $19 million cash payment at closing and up to $3 million in contingent milestone payments. Read More
ISS became the third proxy advisory firm to recommend shareholders vote against the proposed sale of Staar Surgical Co. to Alcon AG, joining Glass, Lewis & Co. LLC and Egan-Jones Ratings Co. Read More
The U.S. Patent and Trademark Office (PTO) has proposed to limit the use of administrative challenges to patents when the patent in dispute is already the subject of litigation in district court, a change that many in the life sciences might see as an improvement over the current hyper-litigious environment. Read More
Tumors suffer metabolic stress, such as oxygen and nutrient deficiency; as a result, altered metabolism is a common feature of tumors. Cancer cells enhance the production of energy and the synthesis of macromolecules to grow at pathologically increased rates. It is crucial to identify genes that modulate cellular fitness under these stressful scenarios. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bruin Biometrics, Catheter Precision, Collplant, Eve Wellness, Eyexora, Fumedica, Grail, Lindus Health, Medtronic, Qview Medical, Samsara, Samsung, Techsomed, Yendou, Y.ora Vision. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aptar, Scanogen. Read More
